Subscribe
shutterstock_1537866854_sundry_photography
Sundry Photography / Shutterstock.com
25 February 2021AmericasMuireann Bolger

Nevro escalates patent dispute with Boston Scientific

Medical device maker Nevro has hit competitor Boston Scientific (BSC) with a lawsuit for allegedly infringing patents that cover a spinal cord stimulation technology.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Medtech
Nevro claims BSC destroyed evidence in patent suit
26 October 2021   Boston Scientific (BSC) and Nevro will testify before a Delaware Federal Court today following pleas from Nevro to delay the trial due to claims that BSC destroyed evidence related to a patent damages case.
Medtech
Beckman Coulter loses late-stage bid to pause infringement proceedings
17 May 2022   The US District Court for the District of Delaware has denied a motion from Beckman Coulter to stay an patent infringement lawsuit involving Sysmex Corporation until parallel proceedings at the US Court of Appeals for the Federal Circuit are concluded.
Big Pharma
Boston Scientific loses stent patent case in uni feud
2 February 2023   Delaware jury finds that the infringement was intentional | Verdict comes in a long-running dispute that touched upon state sovereignty.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Medtech
Nevro claims BSC destroyed evidence in patent suit
26 October 2021   Boston Scientific (BSC) and Nevro will testify before a Delaware Federal Court today following pleas from Nevro to delay the trial due to claims that BSC destroyed evidence related to a patent damages case.
Medtech
Beckman Coulter loses late-stage bid to pause infringement proceedings
17 May 2022   The US District Court for the District of Delaware has denied a motion from Beckman Coulter to stay an patent infringement lawsuit involving Sysmex Corporation until parallel proceedings at the US Court of Appeals for the Federal Circuit are concluded.
Big Pharma
Boston Scientific loses stent patent case in uni feud
2 February 2023   Delaware jury finds that the infringement was intentional | Verdict comes in a long-running dispute that touched upon state sovereignty.

More on this story

Medtech
Nevro claims BSC destroyed evidence in patent suit
26 October 2021   Boston Scientific (BSC) and Nevro will testify before a Delaware Federal Court today following pleas from Nevro to delay the trial due to claims that BSC destroyed evidence related to a patent damages case.
Medtech
Beckman Coulter loses late-stage bid to pause infringement proceedings
17 May 2022   The US District Court for the District of Delaware has denied a motion from Beckman Coulter to stay an patent infringement lawsuit involving Sysmex Corporation until parallel proceedings at the US Court of Appeals for the Federal Circuit are concluded.
Big Pharma
Boston Scientific loses stent patent case in uni feud
2 February 2023   Delaware jury finds that the infringement was intentional | Verdict comes in a long-running dispute that touched upon state sovereignty.

More features

Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court
Cooley adds ex-Gowling partner